INHIBITOR BEA409; CHEMBL127214; N,N-[2,5-O-[DI-4-THIOPHEN-3-YL-BENZYL]-GLUCARYL]-DI-[VALYL-AMIDO-METHANE]; N1,N6-bis[(1S)-2-Methyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-bis[4-(3-thienyl)benzyloxy]-3,4-dihydroxyhexanediamide; 1ec1; C2-Symmetric inhibitor 6; BDBM848; SCHEMBL5967805; symmetric/asymmetric inhibitor 7; DB04547; BEE; Q27458365; (2R,3R,4R,5R)-2,5-Bis[4-(3-thienyl)benzyloxy]-3,4-dihydroxy-N,N'-bis[(S)-1-(methylcarbamoyl)-2-methylpropyl]adipamide; (2R,3R,4R,5R)-3,4-dihydroxy-N,N''-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis({[4-(thiophen-3-yl)phenyl]methoxy})hexanediamide; (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis[[4-(3-thienyl)phenyl]methoxy]hexanediamide